Integrated Diagnostics Holdings plc (IDHC.L)
- Previous Close
0.3445 - Open
0.3400 - Bid 0.3200 x --
- Ask 0.3210 x --
- Day's Range
0.3300 - 0.3490 - 52 Week Range
0.2900 - 0.6280 - Volume
67,708 - Avg. Volume
326,717 - Market Cap (intraday)
1.893M - Beta (5Y Monthly) 0.50
- PE Ratio (TTM)
0.16 - EPS (TTM)
0.0200 - Earnings Date Mar 28, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 16, 2022
- 1y Target Est
25.79
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, including positron emission tomography computed tomography (PET-CT), magnetic resonance imaging (MRI), computed tomography (CT), mammography, ultrasound, x-ray, electromyography (EMG), electroencephalography, electroencephalogram (EEG), and electrocardiogram (ECG), as well as operates cath lab facilities. It operates in Egypt, Sudan, Jordan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.
www.idhcorp.com6,692
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: IDHC.L
Performance Overview: IDHC.L
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IDHC.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IDHC.L
Valuation Measures
Market Cap
189.30M
Enterprise Value
195.95M
Trailing P/E
17.79
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.20
Price/Book (mrq)
3.39
Enterprise Value/Revenue
0.05
Enterprise Value/EBITDA
0.15
Financial Highlights
Profitability and Income Statement
Profit Margin
12.38%
Return on Assets (ttm)
8.66%
Return on Equity (ttm)
16.89%
Revenue (ttm)
4.12B
Net Income Avi to Common (ttm)
510.3M
Diluted EPS (ttm)
0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
860.51M
Total Debt/Equity (mrq)
38.03%
Levered Free Cash Flow (ttm)
-72.17M
Research Analysis: IDHC.L
Company Insights: IDHC.L
IDHC.L does not have Company Insights